All Stories

  1. Contributions of conserved and species-specific CagX (VirB9) domains to the assembly and function of the Helicobacter pylori Cag type IV secretion system
  2. Multiple TonB-dependent transport systems in Helicobacter pylori
  3. Species-specific components of the Helicobacter pylori Cag type IV secretion system
  4. A unique Helicobacter pylori strain to study gastric cancer development
  5. Taurine modulates host cell responses to Helicobacter pylori VacA toxin
  6. Correction: Subdomains of theHelicobacter pyloriCag T4SS outer membrane core complex exhibit structural independence
  7. Subdomains of theHelicobacter pyloriCag T4SS outer membrane core complex exhibit structural independence
  8. The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk
  9. Structural Analysis of Membrane-associated Forms of Helicobacter pylori VacA Toxin
  10. Role of the CagY antenna projection in Helicobacter pylori Cag type IV secretion system activity
  11. Identification of an Essential LolD-Like Protein in Helicobacter pylori
  12. A Positively Selected fur -R88H Mutation Enhances Helicobacter pylori Fitness in a High-Salt Environment and Alters Fur-Dependent Regulation of Gene Expression
  13. Regulation of Helicobacter pylori Urease and Acetone Carboxylase Genes by Nitric Oxide and the CrdRS Two-Component System
  14. Molecular architecture of bacterial type IV secretion systems
  15. Positive Selection of Mutations in the Helicobacter pylori katA 5′ Untranslated Region in a Mongolian Gerbil Model of Gastric Disease
  16. An infection-induced oxidation site regulates legumain processing and tumor growth
  17. Enhanced Fitness of a Helicobacter pylori babA Mutant in a Murine Model
  18. Tracking bacterial effector protein delivery into host cells
  19. Delineation of the pH-Responsive Regulon Controlled by the Helicobacter pylori ArsRS Two-Component System
  20. Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer
  21. Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex
  22. Cryo-EM reveals species-specific components within theHelicobacter pyloriCag type IV secretion system core complex
  23. The Helicobacter pylori Cag Type IV Secretion System
  24. Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis
  25. Lipoprotein Processing and Sorting in Helicobacter pylori
  26. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants
  27. Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells
  28. Structure of a molecular machine in a bacterium that contributes to gastric cancer
  29. Effect of environmental salt concentration on the Helicobacter pylori exoproteome
  30. In Situ Molecular Architecture of the Helicobacter pylori Cag Type IV Secretion System
  31. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization
  32. Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells
  33. Helicobacter pylori VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection
  34. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability
  35. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States
  36. Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability
  37. Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression
  38. Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium
  39. Helicobacter pylori genetic diversification in the Mongolian gerbil model
  40. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA
  41. High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins
  42. Genetic signatures for Helicobacter pylori strains of West African origin
  43. Helicobacter pylori Vacuolating Toxin and Gastric Cancer
  44. Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments
  45. Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy
  46. Magnetic Extraction of Acinetobacter baumannii Using Colistin-Functionalized γ-Fe2O3/Au Core/Shell Composite Nanoclusters
  47. Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis
  48. Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements
  49. Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration
  50. Epithelial Coculture and l-Lactate Promote Growth of Helicobacter cinaedi under H2-Free Aerobic Conditions
  51. Colistin-Functionalized Nanoparticles for the Rapid Capture of Acinetobacter baumannii
  52. Structural organization of membrane-inserted hexamers formed byHelicobacter pyloriVacA toxin
  53. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain
  54. An Overview of Helicobacter pylori VacA Toxin Biology
  55. Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens
  56. Helicobacter pylori and stomach cancer
  57. Type IV secretion system in Helicobacter pylori
  58. Growth phase-dependent composition of the Helicobacter pylori exoproteome
  59. Supporting data for analysis of the Helicobacter pylori exoproteome
  60. Helicobacter pylori AdaptationIn Vivoin Response to a High-Salt Diet
  61. Alteration of theHelicobacter pylorimembrane proteome in response to changes in environmental salt concentration
  62. Regulation ofHelicobacter pyloriVirulence Within the Context of Iron Deficiency
  63. The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration
  64. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10
  65. Genes Required for Assembly of Pili Associated with the Helicobacter pylori cag Type IV Secretion System
  66. Helicobacter pylori outer membrane proteins
  67. Vacuolating Cytotoxin
  68. Human and Helicobacter pylori coevolution shapes the risk of gastric disease
  69. Control of gene expression in Helicobacter pylori using the Tet repressor
  70. Diet, microbial virulence, andHelicobacter pylori-induced gastric cancer
  71. Role of Connexin 43 in Helicobacter pylori VacA-Induced Cell Death
  72. Genome Sequences of Three hpAfrica2 Strains of Helicobacter pylori
  73. Impaired Autophagy, Defective T Cell Homeostasis, and a Wasting Syndrome in Mice with a T Cell-Specific Deletion of Vps34
  74. Flagellar Localization of a Helicobacter pylori Autotransporter Protein
  75. High Dietary Salt Intake Exacerbates Helicobacter pylori-Induced Gastric Carcinogenesis
  76. Functional Plasticity in the Type IV Secretion System of Helicobacter pylori
  77. Structure of the vacuolating toxin VacA from Helicobacter pylori
  78. Genetic analysis of Helicobacter pylori strains from East Asia
  79. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori–infected children
  80. Structural Characterization of the Helicobacter Pylori VacA Toxin by Single Particle Em and X-Ray Crystallography
  81. Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
  82. Analysis ofHelicobacter pylori cagAPromoter Elements Required for Salt-Induced Upregulation of CagA Expression
  83. The Intermediate Region of Helicobacter pylori VacA Is a Determinant of Toxin Potency in a Jurkat T Cell Assay
  84. Role ofHelicobacter pyloriCagL in modulating gastrin expression
  85. Non‐invasive Genotyping of Helicobacter pylori cagA, vacA, and hopQ from Asymptomatic Children
  86. J-Western Forms of Helicobacter pylori cagA Constitute a Distinct Phylogenetic Group with a Widespread Geographic Distribution
  87. Alterations in Helicobacter pylori Triggered by Contact with Gastric Epithelial Cells
  88. An RGD Helper Sequence in CagL of Helicobacter pylori Assists in Interactions with Integrins and Injection of CagA
  89. Helicobacter pylori type IV secretion system
  90. Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity
  91. β-Catenin and p120 Mediate PPARδ-Dependent Proliferation Induced by Helicobacter pylori in Human and Rodent Epithelia
  92. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism
  93. Helicobacter pylori VacA Induces Programmed Necrosis in Gastric Epithelial Cells
  94. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk
  95. Molecular Evolution of the Helicobacter pylori Vacuolating Toxin Gene vacA
  96. Reconstitution of Helicobacter pylori VacA toxin activity from p33 and p55 domains
  97. Analysis of Protein Expression Regulated by the Helicobacter pylori ArsRS Two-Component Signal Transduction System
  98. Analysis of a β-helical region in the p55 domain of Helicobacter pylori vacuolating toxin
  99. In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription
  100. Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection
  101. Helicobacter pylori in Health and Disease
  102. Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis
  103. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer
  104. Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR
  105. Helicobacter pyloriHopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells
  106. Helicobacter pyloriand mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells
  107. Helicobacter pylori VacA Disrupts Apical Membrane-Cytoskeletal Interactions in Gastric Parietal Cells
  108. Helicobacter pylori VacA Subdomain Required for Intracellular Toxin Activity and Assembly of Functional Oligomeric Complexes
  109. β2 Integrin Mediates Entry of a Bacterial Toxin into T Lymphocytes
  110. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain
  111. Host response to Helicobacter pylori infection before initiation of the adaptive immune response
  112. Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets
  113. l-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori
  114. Regulation of Helicobacter pylori cagA Expression in Response to Salt
  115. Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and Growth
  116. Serological Assays for Identification of Human Gastric Colonization by Helicobacter pylori Strains Expressing VacA m1 or m2
  117. Functional Analysis of Neutralizing Antibodies against Clostridium perfringens Epsilon-Toxin
  118. Role ofHelicobacter pyloriOuter Membrane Proteins in Gastroduodenal Disease
  119. Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin
  120. Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses
  121. Helicobacter pylori VacA Toxin Inhibits Human Immunodeficiency Virus Infection of Primary Human T Cells
  122. Random Mutagenesis of Helicobacter pylori vacA To Identify Amino Acids Essential for Vacuolating Cytotoxic Activity
  123. Quantitative Effect of luxS Gene Inactivation on the Fitness of Helicobacter pylori
  124. Protein-Protein Interactions among Helicobacter pylori Cag Proteins
  125. Multiple Chromosomal Loci for the babA Gene in Helicobacter pylori
  126. Requirement of Histidine Kinases HP0165 and HP1364 for Acid Resistance in Helicobacter pylori
  127. Mapping of a Domain Required for Protein-Protein Interactions and Inhibitory Activity of a Helicobacter pylori Dominant-Negative VacA Mutant Protein
  128. Helicobacter pylori vacuolating toxin
  129. Mimicry of a Host Anion Channel by a Helicobacter pylori Pore-Forming Toxin
  130. Analysis ofhopQalleles in East Asian and Western strains ofHelicobacter pylori
  131. The Oxysterol-binding Protein Homologue ORP1L Interacts with Rab7 and Alters Functional Properties of Late Endocytic Compartments
  132. High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy
  133. Genomic Comparison of cag Pathogenicity Island (PAI)-Positive and -Negative Helicobacter pylori Strains: Identification of Novel Markers for cag PAI-Positive Strains
  134. Functional Properties of the p33 and p55 Domains of the Helicobacter pylori Vacuolating Cytotoxin
  135. Helicobacter pylori VacA, a paradigm for toxin multifunctionality
  136. Growth Phase Regulation of flaA Expression in Helicobacter pylori Is luxS Dependent
  137. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy
  138. Heterogeneity among Helicobacter pylori Strains in Expression of the Outer Membrane Protein BabA
  139. Inhibition of primary human T cell proliferation byHelicobacter pylorivacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
  140. Clustering and Redistribution of Late Endocytic Compartments in Response to Helicobacter pylori Vacuolating Toxin
  141. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells
  142. Interactions between p-33 and p-55 Domains of the Helicobacter pylori Vacuolating Cytotoxin (VacA)
  143. Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation
  144. Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH
  145. Expression of Helicobacter pylori Vacuolating Toxin in Escherichia coli
  146. Effects ofHelicobacter pylorion intracellular Ca2+signaling in normal human gastric mucous epithelial cells
  147. Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin
  148. Recovery from lactacidosis-induced glial cell swelling with the aid of exogenous anion channels
  149. Two Different Families of hopQ Alleles in Helicobacter pylori
  150. Global analysis of Helicobacter pylori gene expression in human gastric mucosa
  151. PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments. ONLY PIKfyve EXPRESSION INHIBITS THE CELL-VACUOLATING ACTIVITY OF HELICOBACTER PYLORI VacA TOXIN
  152. Genome-Wide Transcriptional Profiling in a Histidine Kinase Mutant of Helicobacter pylori Identifies Members of a Regulon
  153. Association of Helicobacter pylori Vacuolating Toxin (VacA) with Lipid Rafts
  154. Multiple Oligomeric States of the Helicobacter pylori Vacuolating Toxin Demonstrated by Cryo-electron Microscopy
  155. A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation
  156. In search of the Helicobacter pylori VacA mechanism of action
  157. Antigenic Diversity among Helicobacter pyloriVacuolating Toxins
  158. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease
  159. Amino-Terminal Hydrophobic Region ofHelicobacter pylori Vacuolating Cytotoxin (VacA) Mediates Transmembrane Protein Dimerization
  160. Carboxy-Terminal Proteolytic Processing ofHelicobacter pylori Vacuolating Toxin
  161. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells
  162. Intercellular Communication in Helicobacter pylori: luxS Is Essential for the Production of an Extracellular Signaling Molecule
  163. Cell Vacuolation Induced by the VacA Cytotoxin of Helicobacter pylori Is Regulated by the Rac1 GTPase
  164. A Dominant Negative Mutant of Helicobacter pyloriVacuolating Toxin (VacA) Inhibits VacA-induced Cell Vacuolation
  165. Vacuolating Cytotoxin ( vacA ) Alleles of Helicobacter pylori Comprise Two Geographically Widespread Types, m1 and m2, and Have Evolved Through Limited Recombination
  166. Helicobacter pylori Vacuolating Cytotoxin (VacA) Disorganizes the Cytoskeletal Architecture of Gastric Epithelial Cells
  167. Helicobacter pylori factors associated with disease
  168. Release ofHelicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium
  169. VacA fromHelicobacter pylori: a hexameric chloride channel
  170. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH
  171. Acid-induced expression of an LPS-associated gene inHelicobacter pylori
  172. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity
  173. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
  174. An intracellular target for Helicobacter pylori vacuolating toxin
  175. Acid-induced Dissociation of VacA, theHelicobacter pyloriVacuolating Cytotoxin, Reveals Its Pattern of Assembly
  176. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
  177. High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.
  178. Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells.
  179. Density of Helicobacter pylori Infection In Vivo as Assessed by Quantitative Culture and Histology
  180. The gastrin-histamine sequence
  181. The vacuolating cytotoxin of Helicobacter pylori
  182. Helicobacter pylori and gastric acid: Biological and therapeutic implications
  183. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori
  184. Analysis of Genetic Diversity in Cytotoxin-Producing and Non-Cytotoxin Producing Helicobacter pylori Strains
  185. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  186. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  187. Helicobacter pylori infection in japanese patients with adenocarcinoma of the stomach
  188. Potentiation of Helicobacter pylori Vacuolating Toxin Activity by Nicotine and Other Weak Bases
  189. Characterization of Hela cell vacuoles induced by Helicobacter pylori broth culture supernatant
  190. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
  191. Helicobacter Pylori and Gastroduodenal Disease
  192. Evaluation of cytotoxic activity in fecal filtrates from patients with or enteritis
  193. Yersinia Enterocolitica
  194. The Pathobiology of Campylobacter Infections in Humans
  195. Pseudomonas paucimobilis Empyema After Cardiac Transplantation